De novo anorectal cancers in renal transplant recipients.

被引：0
|
作者：
Rudich, SM [1 ]
Buell, JF [1 ]
Beebe, TM [1 ]
Gross, TG [1 ]
Hanaway, MJ [1 ]
Alloway, RR [1 ]
Trofe, J [1 ]
Woodle, ES [1 ]
机构：
[1] Univ Cincinnati, Div Transplantat, Cincinnati, OH 45221 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2004年 / 4卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
1005
引用
收藏
页码：433 / 433
页数：1
相关论文
共 50 条
  • [1] A clinical experience with Gengraf™ (Abbott cyclosporine) in de novo renal transplant recipients.
    Scandling, J
    Rajagopalan, PR
    Magee, J
    Conti, D
    Mendez, R
    Bronson, D
    Awni, W
    Nabulsi, A
    Hoffman, R
    [J]. TRANSPLANTATION, 2000, 69 (08) : S161 - S161
  • [2] Renal Dysfunction at 12 Months Is Not Associated with Everolimus Exposure in De Novo Renal Transplant Recipients.
    Shihab, F.
    Qazi, Y.
    Mulgaonkar, S.
    McCague, K.
    Patel, D.
    Peddi, V.
    Shaffer, D.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 544 - 544
  • [3] Significant Pharmacokinetic Interaction Between Everolimus and Tacrolimus in De Novo Renal Transplant Recipients.
    Chang, H. -P.
    Lee, C. -Y.
    Si, C. -C.
    Tsai, M. -K.
    Wu, F. -L. Lin
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 538 - 538
  • [4] Blinded Neoral C2 monitoring in de novo renal transplant recipients.
    Lake, KD
    Magee, JC
    Stodart, J
    Mclean, D
    Annesley, TM
    Cibrik, DM
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 255 - 255
  • [5] Everolimus-Facilitated Tacrolimus Minimization Preserves Renal Function in De Novo Renal Transplant Recipients.
    Shihab, F.
    Qazi, Y.
    Kaplan, B.
    Kim, D.
    Mulgaonkar, S.
    Peddi, V.
    Shaffer, D.
    Patel, D.
    McCague, K.
    Vincenti, F.
    [J]. TRANSPLANTATION, 2014, 98 : 538 - 539
  • [6] EVEROLIMUS IN DE NOVO RENAL TRANSPLANT RECIPIENTS
    Prokopenko, E. I.
    [J]. VESTNIK TRANSPLANTOLOGII I ISKUSSTVENNYH ORGANOV, 2010, 12 (02): : 74 - 81
  • [7] Economic evaluation of everolimus with reduced-dose cyclosporine in de novo renal transplant recipients.
    Keown, P
    Ethgen, O
    Yang, XL
    Ricci, JF
    Kessabi, S
    Spaepen, S
    Annemans, L
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 504 - 504
  • [8] Eplet Mismatches and De Novo Donor Surface Antibody Development in Pediatric Renal Transplant Recipients.
    Blanchette, E.
    Bradford, M.
    Warner, P.
    Blosser, C.
    Gimferrer, I.
    Smith, J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 266 - 267
  • [9] Exposure to CsA, and not to everolimus, is associated with impaired renal function in de novo heart transplant recipients.
    Varnous, Shaida
    Livi, Ugolino
    Poncelet, Alain
    Delgado, Juan
    Vermes, Emmanuelle
    Li, Yulan
    Arizon, Jose
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 346 - 346
  • [10] Incidence and Factors Associated with De Novo DSA After BK Viremia in Renal Transplant Recipients.
    Patel, S.
    Kuten, S.
    Knight, R.
    Nguyen, D.
    Graviss, E.
    Gaber, A.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 769 - 769
12345